# Metachronous Pancreatic Metastasis of Myxoid Liposarcoma Successfully Treated With Robotic Spleen‐Preserving Distal Pancreatectomy With Splenic Vessels Resections: A Case Report

## TL;DR

A rare case of pancreatic metastasis from myxoid liposarcoma was successfully treated with a robotic spleen-preserving surgery.

## Contribution

First reported case of metachronous pancreatic metastasis of myxoid liposarcoma treated with robotic spleen-preserving distal pancreatectomy.

## Key findings

- Robotic surgery successfully removed a 6-cm pancreatic metastasis with no recurrence after 3 months.
- The procedure preserved the spleen and used the Warshaw technique for vessel resection.
- No distant metastases were detected, supporting curative resection for isolated cases.

## Abstract

Pancreatic metastasis of myxoid liposarcoma (MLS) after primary resection is extremely rare. Herein, we present a case of metachronous pancreatic metastasis of MLS that was successfully treated with robotic spleen‐preserving distal pancreatectomy (SPDP) using the Warshaw technique. A 60‐year‐old woman underwent radical resection of a 25‐cm MLS in the right thigh after receiving neoadjuvant radiotherapy. The patient developed a 6‐cm solitary pancreatic metastasis of the MLS 2 years later. Because no other distant metastases were detected, robotic SPDP (Warshaw technique) was performed. The operative time was 140 min with minimal blood loss. Follow‐up at 3 months showed no recurrence. To our knowledge, this is the first report of a case of metachronous pancreatic metastasis of MLS successfully treated with robotic SPDP. Curative resection using minimally invasive surgery should be performed for solitary pancreatic metastases from MLS.